About
Telehealth
Research
Innovation
Sports Research
Resources
Readiness check
Wearable Technology
FAQ
Preview App Here
Location
Cleveland, Ohio
Industry
Sports medicine & rehabilitation
Website
Speak with us

Adherence that holds across seasons.

84%
Protocol adherence across seasons
White h2o molecules or atoms, abstract clean , scientific, or medical structures.

Every wearable monitoring protocol has the same problem. Compliance is strong in week one, wobbles in week two, and falls off a cliff somewhere around week three. The behavior is consistent enough across programs that most teams have stopped fighting it.

The University Hospitals Cleveland Medical Center sports medicine program wanted to understand why — and whether device design, not athlete motivation, was the actual variable.

The answer, across two years of continuous wear-time data, is clear.

The study

UH Hospitals partnered with Notus Labs on a multi-sport adherence research program spanning collegiate, high school, and post-surgical cohorts. All athletes wore the Notus Labs armband across full competitive or rehabilitation seasons.

The study measured continuous wear time, sync reliability, and self-reported friction events against clinical and behavioral baselines. No intervention on athlete behavior — the goal was to observe what held compliance up, and what broke it down.

What we measured

Daily wear hours, session-level sync success, charge-cycle compliance, and athlete-reported wear friction events. All data streamed through the standard Notus Labs research pipeline.

Athletes also completed brief weekly check-ins on device comfort, visibility during activity, and whether the data had been reviewed with a clinician that week.

The goal was a full picture of what athletes actually did — not what they said they did.

What the data is showing

Across the cohort, average daily wear time held at 17 hours plus through the full season. Compliance did not show the typical week-three cliff that appears in almost every other wearable protocol on record.

The strongest predictor of sustained adherence wasn't injury severity, sport type, or demographics. It was whether athletes reviewed their own data with a clinician at least once every two weeks.

The second strongest predictor was device friction — specifically, whether the band caught on pads during contact sessions. In UH's program, it didn't.

Adherence isn't discipline. It's the difference between what the device asks for and what it gives back.

What the UH adherence study revealed:

  • Adherence tracked closely with athlete visibility into their own data
  • Device form factor mattered more than expected across contact sports
  • Sync failures had outsized psychological effect on wear rates
  • Two-week clinician review cadence sustained engagement through full seasons
  • Self-reported compliance overstated actual wear by 15 to 20 percent on average

The findings reshaped how UH designs monitoring protocols across the broader sports medicine program — and continue to inform how we think about adherence across every deployment on the Notus Labs platform.

High compliance isn't a sign of exceptional athletes. It's a sign of a device and workflow that don't ask them to be exceptional.

Join Our SMS List!
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
HomeAbout UsTelehealthResearch
Readiness CheckInnovationSports Medicine ResearchAthlete App DemoWearable Technology
Privacy PolicyTerms of ServiceGet in Touch
© Copyright Notus Labs
Notus Labs Inc.
2728 Euclid Avenue Suite 300 Cleveland, OH 44115 United States
(877) 310-1769
support@notus-labs.com
Notus Labs is a wearable biomechanical monitoring platform for orthopedic care, sports medicine research, and athletic performance. Notus Labs is not a medical device, does not provide medical advice, and does not diagnose, treat, cure, or prevent any condition or injury. All biomechanical data is intended to support clinical decision-making by licensed healthcare professionals and research workflows conducted under institutional IRB approval. Return-to-play and clearance decisions remain the sole responsibility of the treating clinician. Research partnerships are conducted with Case Western Reserve University, University Hospitals Cleveland Medical Center, and other affiliated institutions under formal data-sharing agreements.